psyllium

Botanicalexperimental

Psyllium, or Isabgol or ispaghula, is the common name used for several members of the plant genus Plantago whose seeds are used commercially for the production of mucilage. Psyllium is mainly used as a dietary fiber to relieve symptoms of both constipation and mild diarrhea, and occasionally as a food thickener. Allergy to psyllium is common in workers frequently exposed to the substance. — Wikipedia

Clinical trial activity

50 trials · 58 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
7
Phase 3
4
Phase 4
6

Earliest trial started May 1, 1988 (NCT01582282)

Timeline

1990s

  1. Jan 1, 1992

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2024

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetSupplementation

    supplementation

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • hydrocil instant
  • metamucil
  • metamucil
  • modane bulk
  • mylanta fiber
  • plantago
  • plantago
  • plantago seed
  • plantago seed
  • plantain
  • psyllium
  • psyllium
  • psyllium
  • psyllium
  • psyllium husk
  • psyllium husk
  • psyllium husk
  • syllact

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07202481N/AOct 31, 2025Federal University of Minas Gerais
NCT06785831N/AJan 20, 2025Nutrition Institute, Slovenia, University of Ljubljana
NCT06639984Phase 3Nov 1, 2024Duke University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT06551948N/AJan 1, 2024University of East Anglia, University of Nottingham
NCT06972134N/ADec 15, 2023Duhok University
NCT06166615Phase 2/Phase 3 (Phase 3)Dec 15, 2023Seoul National University
NCT06291272N/AOct 15, 2023Quadram Institute, University of Nottingham
NCT05906589N/AJul 25, 2023University of Aberdeen
NCT05911347N/AMay 9, 2023University of East Anglia, University of Nottingham
NCT05528146N/ADec 1, 2022Hung Kaung University
NCT05619341N/AOct 28, 2022University of Nottingham
NCT05341180Phase 2/Phase 3 (Phase 3)May 27, 2022All India Institute of Medical Sciences
NCT05825963N/AApr 12, 2022Okan University
NCT04806386N/AJul 21, 2021Harvard University
NCT04829760N/AMay 13, 2021University of Florida
NCT04695340N/AFeb 1, 2021University of Nice Sophia Antipolis
NCT04619095N/AJan 1, 2021Alberta Children's Hospital Research Institute, University of Calgary
NCT04547790N/ADec 31, 2020Mayo Clinic
NCT06188728N/ASep 7, 2020University of Peshawar
NCT03998488Phase 2Jul 31, 2019Cornell University, Crohn's and Colitis Foundation
Showing 20 of 50 trials
Page 1 / 3

Organizations

Research & Development (58)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of NottinghamAcademic/Hospital8812013
Procter and GambleFor profit4421988
Department of Veteran AffairsGovernment3222008
Duke UniversityAcademic/Hospital2122012
Ironwood PharmaceuticalsFor profit2012013
Rush UniversityAcademic/Hospital2112010
University of East AngliaAcademic/Hospital2012023
Aalborg UniversityAcademic/Hospital1112011
Alberta Children's Hospital Research InstituteAcademic/Hospital1012021
All India Institute of Medical SciencesAcademic/Hospital1112022
Canadian Cystic Fibrosis FoundationAcademic/Hospital1012016
Chinese University of Hong KongAcademic/Hospital1112009
Cornell UniversityAcademic/Hospital1112019
Crohn's and Colitis FoundationAcademic/Hospital1012019
Dr. Falk Pharma GmbHFor profit1012012
Duhok UniversityAcademic/Hospital1112023
Federal University of Minas GeraisAcademic/Hospital1112025
Free University of AmsterdamAcademic/Hospital1012016
Harvard UniversityAcademic/Hospital1112021
Hung Kaung UniversityAcademic/Hospital1112022
58 organizations
Page 1 / 3